Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medical Supply Manufacturing Business		1.67T	1.49T	1.34T	1.30T	1.08T
Medical Supply Manufacturing Business Growth		12.17%	10.78%	3.11%	20.72%	12.88%
Total		1.67T	1.49T	1.34T	1.30T	1.08T
Total Growth		12.17%	10.78%	3.11%	20.72%	12.88%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
South Korea		1.49T	1.42T	1.29T	1.25T	1.03T
South Korea Growth		4.91%	10.67%	2.88%	21.22%	13.67%
Japan		41.16B	45.89B	43.91B	42.00B	39.12B
Japan Growth		-10.32%	4.51%	4.55%	7.37%	-4.76%
Others		133.98B	19.21B	7.34B	10.92B	8.12B
Others Growth		597.51%	161.70%	-32.78%	34.53%	44.51%
Algeria		1.19B	-	6.25B	-	-
Indonesia		-	-	-	-	828.01M
Total		1.67T	1.49T	1.34T	1.30T	1.08T
Total Growth		12.17%	10.78%	3.11%	20.72%	12.88%

Source: S&P Global Market Intelligence.